These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38803174)
1. Preparation of a Novel Multifunctional Cationic Liposome Drug-carrying System and its Functional Study on Lung Cancer. Kong Y; Xu L; Cao J Anticancer Agents Med Chem; 2024; 24(14):1085-1095. PubMed ID: 38803174 [TBL] [Abstract][Full Text] [Related]
2. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles. Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595 [TBL] [Abstract][Full Text] [Related]
3. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer. Li S; Li X; Ding J; Han L; Guo X Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163 [No Abstract] [Full Text] [Related]
5. Celastrol-loaded polymeric mixed micelles shows improved antitumor efficacy in 4 T1 bearing xenograft mouse model through spatial targeting. Gautam S; Singh N; Marwaha D; Rai N; Sharma M; Tiwari P; Singh S; Kumar Bakshi A; Kumar A; Agarwal N; Prakash Shukla R; Ranjan Mishra P Int J Pharm; 2024 Jun; 659():124234. PubMed ID: 38763310 [TBL] [Abstract][Full Text] [Related]
6. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy. Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409 [TBL] [Abstract][Full Text] [Related]
7. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers. Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983 [TBL] [Abstract][Full Text] [Related]
8. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy. Wang WY; Cao YX; Zhou X; Wei B Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632 [No Abstract] [Full Text] [Related]
9. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation Wang Y; Guo M; Lin D; Liang D; Zhao L; Zhao R; Wang Y Drug Deliv; 2021 Dec; 28(1):1510-1523. PubMed ID: 34263685 [TBL] [Abstract][Full Text] [Related]
10. Enzymatic multifunctional biodegradable polymers for pH- and ROS-responsive anticancer drug delivery. Su M; Xiao S; Shu M; Lu Y; Zeng Q; Xie J; Jiang Z; Liu J Colloids Surf B Biointerfaces; 2020 Sep; 193():111067. PubMed ID: 32388121 [TBL] [Abstract][Full Text] [Related]
11. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer. Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252 [TBL] [Abstract][Full Text] [Related]
12. PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells. Xu S; Cui F; Huang D; Zhang D; Zhu A; Sun X; Cao Y; Ding S; Wang Y; Gao E; Zhang F Int J Nanomedicine; 2019; 14():17-32. PubMed ID: 30587982 [TBL] [Abstract][Full Text] [Related]
13. Novel co-delivery of oridonin and docetaxel nanoliposome for an enhanced antitumor effect on esophageal cancer. Chen X; Mao H; Peng F; Fan J; Yang F J Gene Med; 2024 Aug; 26(8):e3725. PubMed ID: 39134478 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic effect and MR molecular imaging of FA-PEG-FePt/DDP nanoliposomes in AMF on ovarian cancer. Bian X; Guo T; Chen G; Nie D; Yue M; Zhu Y; Lin M Int J Nanomedicine; 2024; 19():5227-5243. PubMed ID: 38855734 [TBL] [Abstract][Full Text] [Related]
15. Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery. Su M; Xie J; Zeng Q; Shu M; Liu J; Jiang Z Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111125. PubMed ID: 32600724 [TBL] [Abstract][Full Text] [Related]
17. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo. Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681 [TBL] [Abstract][Full Text] [Related]
18. A Novel Targeted Therapy System for Cervical Cancer: Co-Delivery System of Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier. Ye H; Chu X; Cao Z; Hu X; Wang Z; Li M; Wan L; Li Y; Cao Y; Diao Z; Peng F; Liu J; Xu L Int J Nanomedicine; 2021; 16():1051-1066. PubMed ID: 33603368 [TBL] [Abstract][Full Text] [Related]
19. Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer. Chaudhuri A; Naveen Kumar D; Kumar D; Kumar Agrawal A Eur J Pharm Biopharm; 2024 Aug; 201():114386. PubMed ID: 38950717 [TBL] [Abstract][Full Text] [Related]
20. Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation. Li M; Pei J; Ma Z; Fu J; Chen F; Du S Cancer Chemother Pharmacol; 2020 Apr; 85(4):731-739. PubMed ID: 32146495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]